Bronnen:
- Cohen SB, Tanaka Y, Mariette X, et al. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis. 2017;76:1253-62.
Bronnen:
feb 2025 | Arthritis psoriatica, Orthopedie, Spondyloartritis
feb 2025 | RA
feb 2025 | RA, Vaccinatie
feb 2025
feb 2025 | Jicht
jan 2025
2 okt 2024 om 18:30 | Arthritis psoriatica, Spondyloartritis
30 jul 2024 | Artritis, Psoriasis
11 apr 2024 om 18:30 | Spondyloartritis
11 mrt 2024 | Immuuntherapie, SLE
8 nov 2023 | Spondyloartritis
30 okt 2023 om 20:00 | Artrose
3 okt 2023 om 18:30 | Spondyloartritis
6 mrt 2023 | Arthritis psoriatica, Spondyloartritis
4 okt 2022 om 18:30 | Spondyloartritis
Psoriasis, Spondyloartritis
nov 2024 | RA
nov 2024 | Artrose
nov 2024 | SLE
nov 2024 | Osteoporose
nov 2024 | Artrose
nov 2024
nov 2024 | RA
nov 2024 | Arthritis psoriatica, Artritis, Artrose, JIA, Jicht, Osteoporose, RA, Sjögren, SLE, Spondyloartritis
nov 2024 | RA
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE